Gene · 23552
Papers1,583
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,583
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Silica Nanoparticles Shed Light on Intriguing Cellular Pathways in Human Tracheal Smooth Muscle Cells: Revealing COX-2/PGE2 Production through the EGFR/Pyk2 Signaling Axis. | Biomedicines | 2024 | 38255212 | PubTator, text mining | PubMed |
| Role of proliferative markers in assessing recurrences in surgical margins of oral squamous cell carcinoma: A systematic review. | J Oral Maxillofac Pathol | 2023 | 38304496 | PubTator, text mining | PubMed |
| Title Expression of FOXO3 and MAPK1 Genes in Patients with Benign Salivary Gland Tumors. | J Clin Med | 2023 | 38202222 | PubTator, text mining | PubMed |
| Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors. | Cancers (Basel) | 2023 | 38201534 | PubTator, text mining | PubMed |
| Features of Distribution of the Allelic Variant of the OAS1 Gene Associated with Severe Form of the Coronavirus Infection in the Russian and Global Populations. | Bull Exp Biol Med | 2023 | 38191878 | PubTator, text mining | PubMed |
| Glioblastoma may evade immune surveillance through primary cilia-dependent signaling in an IL-6 dependent manner. | Front Oncol | 2023 | 38188300 | PubTator, text mining | PubMed |
| The current status and future of PD-L1 in liver cancer. | Front Immunol | 2023 | 38155974 | PubTator, text mining | PubMed |
| Recent Progress in CDK4/6 Inhibitors and PROTACs. | Molecules | 2023 | 38138549 | PubTator, text mining | PubMed |
| The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity. | Biomedicines | 2023 | 38137461 | PubTator, text mining | PubMed |
| Distinct states of nucleolar stress induced by anticancer drugs. | Elife | 2023 | 38099650 | PubTator, text mining | PubMed |
| Regulation of CMGC kinases by hypoxia. | BMB Rep | 2023 | 37915135 | PubTator, text mining | PubMed |
| Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation. | Nat Commun | 2023 | 37903757 | PubTator, text mining | PubMed |
| Transcription and chromatin regulation by TAF4b during cellular quiescence of developing prospermatogonia. | Front Cell Dev Biol | 2023 | 37900284 | PubTator, text mining | PubMed |
| Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression. | Cells | 2023 | 37830558 | PubTator, text mining | PubMed |
| Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. | Front Oncol | 2023 | 37810967 | PubTator, text mining | PubMed |
| The Role of Long Non-Coding RNAs in Cardiovascular Diseases. | Int J Mol Sci | 2023 | 37762106 | PubTator, text mining | PubMed |
| Myeloid-intrinsic cell cycle-related kinase drives immunosuppression to promote tumorigenesis. | iScience | 2023 | 37731616 | PubTator, text mining | PubMed |
| Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins. | Clin Proteomics | 2023 | 37705009 | PubTator, text mining | PubMed |
| Toward the appropriate interpretation of Alphafold2. | Front Artif Intell | 2023 | 37664078 | PubTator, text mining | PubMed |
| Biological functions and research progress of eIF4E. | Front Oncol | 2023 | 37601696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23552/papers?page=3